PTC wins bid for Sangamo's Fabry disease gene therapy in bankruptcy

August 12, 2026 4:02 PM

PTC Therapeutics (NASDAQ: PTCT) announced it was selected as the winning bidder to acquire ST-920, a one-time administered AAV gene ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found